Article

jdsupra.comjdsupra.com on 2018-08-31 22:08

Private Equity and Venture Capital Pre-IPO Investments are now used by the Hong Kong Stock Exchange to Validate Pre-Revenue/Profit Biotech Companies

On April 30, 2018, the new listing regime published by The Stock Exchange of Hong Kong Limited (the “Exchange”) for companies from emerging and ...

Related news